💹 Your Post-Notable Earnings Report (Sep 2)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks

Unsubscribe ⚠️ Trump Issued Direct Warning: "Don't Touch This American Stock" (ad) Dear Reader, I hope you are having a great Tuesday! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities). The Sports Dynasty Stock Wall Street Is Sleeping On (ad)* Athletes and influencers are turning game-day gear into viral merch — and one overlooked stock could ride a wave of BILLIONS in revenue. The Early Signals Are Already Here - The Stock Could Be Big 👉 Get the name and the ticker Symbol Company Earning Date EPS Surprise % BABA 08/29 -3.08% LI 08/28 % BURL 08/28 25.20% BBY 08/28 4.92% DKS 08/28 2.10% WOOF 08/28 350.00% DG 08/28 19.23% MRVL 08/28 -1.96% HRL 08/28 -14.63% AFRM 08/28 81.82% AMBA 08/28 25.42% ULTA 08/28 14.91% ADSK 08/28 0.58% BBWI 08/28 0.00% ANF 08/27 2.20% Click Here to View Your Full Report Before Market Open After Market Close Biotech Breakthrough: NanoViricides Advances Dual-Action Drug Into Trials (ad)** NanoViricides (NYSE: NNVC) is advancing a therapy that could redefine modern medicine. Its lead drug, NV-387, now entering Phase II trials, has shown preclinical success not only in stopping lethal viral infections but also in preventing dormant cancer cells from reactivating. By attacking viruses while suppressing IL-6 cytokine inflammation—a known driver of metastasis—NV-387 offers a dual line of defense. With infections like COVID, RSV, and flu surging, this first-in-class therapy is uniquely positioned to address two massive health challenges at once. 📈 Get the Full Story on NV-387's Phase II Breakthrough 🥇 Top Gold Stocks to Watch as Gold Hits All-Time Highs (ad) 🏆 Gold Hits Record Highs — and It's Not Slowing Down Gold prices have climbed steadily over the past two years — soaring to an all-time high of $3,357/oz in April 2025 📈 And with market volatility and tariff uncertainty still looming, this rally shows no signs of stopping 👉 Click Here to Download the Top 4 Gold Stocks Report 📊 + Get 2 FREE Bonus Reports (By clicking the links above, you agree to receive future email alerts from us and our email partners. You can opt out at any time.) How to use EPS Surprice in your Post-Earnings trading strategies: Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it. Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company. At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. To your trading success, Support Team Daily Options Signals PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology. StockEarnings SMS is Here! Join SMS Text and never miss any stock trade alerts or special offers from StockEarnings and our advertising partners ever again... Click right here to join StockEarnings SMS List

(ad)* This message is a PAID ADVERTISEMENT for Digital Brands Group (DBGI) from i2i Marketing Group, LLC. StockEarnings, Inc. has received a fixed fee of $2500 from i2i Marketing Group, LLC for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between September 01, 2025 and September 05, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Digital Brands Group (DBGI) or i2i Marketing Group, LLC. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Digital Brands Group (DBGI) on Edge on the street website for additional information about the relationship between i2i Marketing Group, LLC and Digital Brands Group (DBGI). (ad)** This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between September 2, 2025 and September 5, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS Unsubscribe Today's Bonus Content: 3 Small-Caps Positioned for What's Coming Next